CN113645962A - 含有富马酸二甲酯的肠溶片剂 - Google Patents

含有富马酸二甲酯的肠溶片剂 Download PDF

Info

Publication number
CN113645962A
CN113645962A CN202080025339.0A CN202080025339A CN113645962A CN 113645962 A CN113645962 A CN 113645962A CN 202080025339 A CN202080025339 A CN 202080025339A CN 113645962 A CN113645962 A CN 113645962A
Authority
CN
China
Prior art keywords
enteric
tablet
fibrosis
coated tablet
enteric coated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080025339.0A
Other languages
English (en)
Chinese (zh)
Inventor
金明华
表定忍
毛钟贤
李哲宇
池贤具
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kulak Co Ltd
Original Assignee
Kulak Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kulak Co Ltd filed Critical Kulak Co Ltd
Publication of CN113645962A publication Critical patent/CN113645962A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202080025339.0A 2019-05-31 2020-05-21 含有富马酸二甲酯的肠溶片剂 Pending CN113645962A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2019-0064576 2019-05-31
KR20190064576 2019-05-31
PCT/KR2020/006647 WO2020242132A1 (ko) 2019-05-31 2020-05-21 디메틸푸마르산염을 함유한 장용성 정제

Publications (1)

Publication Number Publication Date
CN113645962A true CN113645962A (zh) 2021-11-12

Family

ID=73553277

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080025339.0A Pending CN113645962A (zh) 2019-05-31 2020-05-21 含有富马酸二甲酯的肠溶片剂

Country Status (10)

Country Link
US (2) US20220087942A1 (US07968547-20110628-C00004.png)
EP (1) EP3977986A4 (US07968547-20110628-C00004.png)
JP (2) JP7224067B2 (US07968547-20110628-C00004.png)
KR (1) KR102197465B1 (US07968547-20110628-C00004.png)
CN (1) CN113645962A (US07968547-20110628-C00004.png)
AU (1) AU2020283238B2 (US07968547-20110628-C00004.png)
BR (1) BR112021018452B1 (US07968547-20110628-C00004.png)
CA (1) CA3135946C (US07968547-20110628-C00004.png)
MX (1) MX2021012441A (US07968547-20110628-C00004.png)
WO (1) WO2020242132A1 (US07968547-20110628-C00004.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3135946C (en) * 2019-05-31 2022-08-09 Myung-Hwa Kim Enteric tablet containing dimethyl fumarate
KR20220133807A (ko) 2021-03-25 2022-10-05 주식회사 큐라클 특정 약동학적 매개변수를 나타내는 디메틸푸마레이트를 유효성분으로 함유한 약학적 조성물
KR20240069303A (ko) * 2022-11-11 2024-05-20 주식회사 대웅제약 방출 제어형 약학적 조성물

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1325302A (zh) * 1998-11-19 2001-12-05 富马法姆股份公司 富马酸二烷基酯的用途
KR20100066742A (ko) * 2008-12-10 2010-06-18 삼일제약주식회사 안정화된 프로톤 펌프 억제제 함유 약학 조성물
US20120034274A1 (en) * 2009-01-09 2012-02-09 Forward Pharma A/S Pharmaceutical composition comprising one or more fumaric acid esters
CN104288774A (zh) * 2014-04-21 2015-01-21 河南省健康伟业生物医药研究股份有限公司 一种肠溶包衣、富马酸二甲酯肠溶制剂及其制备方法
CN104352441A (zh) * 2014-10-16 2015-02-18 济南百诺医药科技开发有限公司 一种富马酸二甲酯肠溶微丸及其制备方法
WO2015086467A1 (en) * 2013-12-12 2015-06-18 Almirall, S.A. Pharmaceutical compositions comprising dimethyl fumarate
CN104971048A (zh) * 2015-07-01 2015-10-14 上海汇伦生命科技有限公司 富马酸二甲酯肠溶微丸及其制备方法
US20160067206A1 (en) * 2013-02-13 2016-03-10 Kyungpook National Univerity Industry- Academic Cooperation Foundation Composition for preventing or treating renal fibrosis comprising dimethylfumarate as active ingredient
KR20160076928A (ko) * 2014-12-23 2016-07-01 한미약품 주식회사 푸마르산 에스테르를 함유하는 미니-정제 형태의 약제학적 제제
US20160346393A1 (en) * 2015-06-01 2016-12-01 Sun Pharmaceutical Industries Limited Pharmaceutical compositions of dimethyl fumarate
CN107205985A (zh) * 2015-02-08 2017-09-26 阿尔科米斯制药爱尔兰有限公司 富马酸单甲酯前药组合物
WO2018077479A1 (en) * 2016-10-25 2018-05-03 Pharmathen S.A. Pharmaceutical compositions comprising a fumaric acid ester and method for the preparation thereof
CN108430462A (zh) * 2015-12-31 2018-08-21 波尔法玛制药工厂股份公司 包括富马酸二甲酯的肠溶包衣口服药物制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19848260C2 (de) 1998-10-20 2002-01-17 Fumapharm Ag Muri Fumarsäure-Mikrotabletten
KR20090028047A (ko) 2007-09-13 2009-03-18 경북대학교 산학협력단 디메틸푸마레이트의 신규 용도
NZ617130A (en) 2009-04-29 2015-06-26 Biogen Ma Inc Treatment of neurodegeneration and neuroinflammation
CN105682648A (zh) * 2013-08-26 2016-06-15 前进制药公司 用于以低的日剂量施用的含富马酸二甲酯的药物组合物
EP3110408B1 (en) * 2014-02-28 2019-01-16 Banner Life Sciences LLC Controlled release enteric soft capsules of fumarate esters
MA40985A (fr) * 2014-11-17 2017-09-26 Biogen Ma Inc Méthodes de traitement de la sclérose en plaques
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
US20180064653A1 (en) * 2015-03-17 2018-03-08 Hetero Labs Limited Pharmaceutical compositions of dimethyl fumarate
WO2017056107A1 (en) * 2015-09-28 2017-04-06 Natco Pharma Ltd Pharmaceutical compositions of dimethyl fumarate
CA3135946C (en) * 2019-05-31 2022-08-09 Myung-Hwa Kim Enteric tablet containing dimethyl fumarate

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1325302A (zh) * 1998-11-19 2001-12-05 富马法姆股份公司 富马酸二烷基酯的用途
KR20100066742A (ko) * 2008-12-10 2010-06-18 삼일제약주식회사 안정화된 프로톤 펌프 억제제 함유 약학 조성물
US20120034274A1 (en) * 2009-01-09 2012-02-09 Forward Pharma A/S Pharmaceutical composition comprising one or more fumaric acid esters
US20160067206A1 (en) * 2013-02-13 2016-03-10 Kyungpook National Univerity Industry- Academic Cooperation Foundation Composition for preventing or treating renal fibrosis comprising dimethylfumarate as active ingredient
CN105813634A (zh) * 2013-12-12 2016-07-27 阿尔米雷尔有限公司 包含反丁烯二酸二甲酯的药物组合物
WO2015086467A1 (en) * 2013-12-12 2015-06-18 Almirall, S.A. Pharmaceutical compositions comprising dimethyl fumarate
CN104288774A (zh) * 2014-04-21 2015-01-21 河南省健康伟业生物医药研究股份有限公司 一种肠溶包衣、富马酸二甲酯肠溶制剂及其制备方法
CN104352441A (zh) * 2014-10-16 2015-02-18 济南百诺医药科技开发有限公司 一种富马酸二甲酯肠溶微丸及其制备方法
KR20160076928A (ko) * 2014-12-23 2016-07-01 한미약품 주식회사 푸마르산 에스테르를 함유하는 미니-정제 형태의 약제학적 제제
CN107205985A (zh) * 2015-02-08 2017-09-26 阿尔科米斯制药爱尔兰有限公司 富马酸单甲酯前药组合物
US20160346393A1 (en) * 2015-06-01 2016-12-01 Sun Pharmaceutical Industries Limited Pharmaceutical compositions of dimethyl fumarate
CN104971048A (zh) * 2015-07-01 2015-10-14 上海汇伦生命科技有限公司 富马酸二甲酯肠溶微丸及其制备方法
CN108430462A (zh) * 2015-12-31 2018-08-21 波尔法玛制药工厂股份公司 包括富马酸二甲酯的肠溶包衣口服药物制剂
WO2018077479A1 (en) * 2016-10-25 2018-05-03 Pharmathen S.A. Pharmaceutical compositions comprising a fumaric acid ester and method for the preparation thereof

Also Published As

Publication number Publication date
JP2023026417A (ja) 2023-02-24
MX2021012441A (es) 2022-10-07
AU2020283238A1 (en) 2022-01-06
KR20200138005A (ko) 2020-12-09
EP3977986A4 (en) 2022-07-20
WO2020242132A1 (ko) 2020-12-03
EP3977986A1 (en) 2022-04-06
AU2020283238B2 (en) 2022-07-07
JP7224067B2 (ja) 2023-02-17
BR112021018452A2 (US07968547-20110628-C00004.png) 2021-12-21
JP2022519933A (ja) 2022-03-25
KR102197465B1 (ko) 2020-12-31
CA3135946C (en) 2022-08-09
BR112021018452B1 (pt) 2022-10-04
US20240180841A1 (en) 2024-06-06
CA3135946A1 (en) 2020-12-03
US20220087942A1 (en) 2022-03-24

Similar Documents

Publication Publication Date Title
AU2019268049B2 (en) Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose
US11173123B2 (en) Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
EP2566462B1 (en) Immediate release formulations and dosage forms of gamma-hydroxybutyrate
EP2341910B1 (en) Immediate release dosage forms of sodium oxybate
US7094427B2 (en) Combination immediate release controlled release levodopa/carbidopa dosage forms
US20240180841A1 (en) Enteric tablet containing dimethyl fumarate
WO2017208136A1 (en) Pharmaceutical composition of dapagliflozin co-crystal
US20100247643A1 (en) Oral formulations
EP3437645A1 (en) Film-coated tablet having high chemical stability of active ingredient
KR102104507B1 (ko) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법
RU2786364C1 (ru) Энтеросолюбильная таблетка, содержащая диметилфумарат
WO2021106004A1 (en) Pharmaceutical composition of s-adenosylmethionine
JP7195354B2 (ja) 浸食マトリックス中に１またはそれ以上のフマル酸エステルを含む医薬製剤
JP2009525953A (ja) ジバルプロ酸及びその誘導体の徐放性製剤
JP2022042886A (ja) アビラテロン酢酸エステル含有製剤
JP2021181483A (ja) 低１日用量で投与するためのフマル酸ジメチルを含む医薬組成物
MX2013010661A (es) Preparacion solida.

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Jin Minghua

Inventor after: Biao Dingren

Inventor after: Mou Zhongxuan

Inventor after: Li Zheyou

Inventor after: Chi Xianjiu

Inventor before: Jin Minghua

Inventor before: Biao Dingren

Inventor before: Mao Zhongxian

Inventor before: Li Zheyu

Inventor before: Chi Xianju